Disease, Disability, and Injury Prevention and Control Special Interest Project (SIP): Initial Review, 28437 [2011-12083]

Download as PDF Federal Register / Vol. 76, No. 95 / Tuesday, May 17, 2011 / Notices 28437 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Interest Project (SIP): Initial Review Disease, Disability, and Injury Prevention and Control Special Interest Projects (SIPs): Initial Review Disease, Disability, and Injury Prevention and Control Special Interest Project (SIP): Initial Review The meeting announced below concerns ‘‘Case Control Study of Chlamydia and Infertility among Women Assessed for Tubal Disease or Treated by Assisted Reproductive Technology, SIP11–048, Panel F,’’ initial review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: The meeting announced below concerns ‘‘Systematic Review of Effective Community-based Interventions of Clinical Preventive Services for Older Adults SIP11–045, and Measuring Impact of MultiComponent Interventions to Prevent Older Adult Falls and Assessing Sustainability and Scalability, SIP 11– 046, Panel D,’’ initial review. Time and Date: 11 a.m.–5 p.m., June 22, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Case Control Study of Chlamydia and Infertility among Women Assessed for Tubal Disease or Treated by Assisted Reproductive Technology, SIP11– 048, Panel F,’’ initial review. Contact Person for More Information: Brenda Colley Gilbert, PhD, MPH, Director, Extramural Research Program Office, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop K–92, BJC4@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Emcdonald on DSK2BSOYB1PROD with NOTICES Dated: May 5, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–12075 Filed 5–16–11; 8:45 am] BILLING CODE 4163–18–P In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11 a.m.–5 p.m., June 16, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Systematic Review of Effective Community-based Interventions of Clinical Preventive Services for Older Adults SIP11– 045, and Measuring Impact of MultiComponent Interventions to Prevent Older Adult Falls and Assessing Sustainability and Scalability, SIP 11–046, Panel D’’, initial review. Contact Person for More Information: Brenda Colley Gilbert, PhD, M.P.H., Director, Extramural Research Program Office, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop K–92, BJC4@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: May 5, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for isease Control and Prevention. [FR Doc. 2011–12071 Filed 5–16–11; 8:45 am] BILLING CODE 4163–18–P VerDate Mar<15>2010 16:21 May 16, 2011 Jkt 223001 PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 The meeting announced below concerns ‘‘Patient Preferences and Needs in Ovarian Cancer Care, SIP11–042 Panel C,’’ initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11 a.m.–5 p.m., June 14, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Patient Preferences and Needs in Ovarian Cancer Care, SIP11–042, Panel C,’’ initial review. Contact Person for More Information: Brenda Colley Gilbert, PhD, M.P.H., Director, Extramural Research Program Office, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop K–92, BJC4@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: May 5, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–12083 Filed 5–16–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Interest Project (SIP): Initial Review The meeting announced below concerns ‘‘Validation of Self-Reported Sleep Surveillance Measures, SIP11– 047, Panel E,’’ initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act E:\FR\FM\17MYN1.SGM 17MYN1

Agencies

[Federal Register Volume 76, Number 95 (Tuesday, May 17, 2011)]
[Notices]
[Page 28437]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-12083]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Interest Project (SIP): Initial Review

    The meeting announced below concerns ``Patient Preferences and 
Needs in Ovarian Cancer Care, SIP11-042 Panel C,'' initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 11 a.m.-5 p.m., June 14, 2011 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of ``Patient Preferences and 
Needs in Ovarian Cancer Care, SIP11-042, Panel C,'' initial review.
    Contact Person for More Information: Brenda Colley Gilbert, PhD, 
M.P.H., Director, Extramural Research Program Office, National 
Center for Chronic Disease Prevention and Health Promotion, CDC, 
4770 Buford Highway, NE., Mailstop K-92, BJC4@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: May 5, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-12083 Filed 5-16-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.